title: [Kidney nephrectomy after allograft failure].
abstract: The number of kidney-transplant patients that return to dialysis therapy after a failed kidney allograft is increasing sharply. These patients differ from patients treated with chronic dialysis, but who have never received a transplant; i.e., former transplanted patients display a higher risk of morbidity-mortality, particularly from cardiovascular and infectious complications. The management of immunosuppression has not been codified for patients with a failed kidney allograft: immunosuppressive therapy can be either abruptly stopped or progressively reduced. In addition, nephrectomy of the failed allograft is debatable. Some advocate this procedure only when there is intolerance, e.g., gross hematuria, local pain, or unexplained inflammatory syndrome. In contrast, others propose a systematic nephrectomy, mainly to reveal anti-HLA antibodies within peripheral blood that may have been adsorbed within the failed allograft, and are not detected, even using sensitive techniques. Prospective studies are warranted to answer these issues.
authors: Département de néphrologie et de transplantation d'organe, CHU Rangueil, TSA 50032, 31059 Toulouse cedex 9, France.
authors: Arnaud
authors: A
authors: Del Bello
authors: Lionel
authors: L
authors: Rostaing
authors: Nicolas
authors: N
authors: Congy-Jolivet
authors: Federico
authors: F
authors: Sallusto
authors: Xavier
authors: X
authors: Gamé
authors: Nassim
authors: N
authors: Kamar
mesh_terms: D064591:Allografts; D006084:Graft Rejection / Q000601:surgery*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D007674:Kidney Diseases / Q000601:surgery*; D016030:Kidney Transplantation; D009392:Nephrectomy / Q000379:methods*; D006435:Renal Dialysis / Q000379:methods*; D017211:Treatment Failure
chemical_list: D007166:Immunosuppressive Agents